secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 77118 grounded facts newest October 13, 2026, 5:25 PM ET RSS · JSON

Showing 1601–1650 of 33813

Departed

Derek Small

Director
INVA · Innoviva, Inc.
Effective
2026-05-12
Filed
May 18, 2026, 4:21 PM ET
On May 12, 2026, Derek Small and Mark DiPaolo Esq. tendered their resignations from the Board of Directors of Innoviva, Inc.
Departed

James Richardson

Executive Vice President and Chief Financial Officer
INSE · Inspired Entertainment, Inc.
Successor
Craig Wilson
Filed
May 18, 2026, 4:15 PM ET
announced that James Richardson had stepped down from his role as Executive Vice President and Chief Financial Officer of the Company.
Departed

Xinliang Li

Director
AIXN · AiXin Life International, Inc.
Effective
2026-05-18
Filed
May 18, 2026, 4:15 PM ET
Effective May 18, 2026, Aixin Life International, Inc. (the “Company”) accepted the resignation of Mr. Xinliang Li a/k/a Christopher Lee from the Company’s Board of Directors.
Departed

Stefan D. Loren

Class III Director
CLRB · Cellectar Biosciences, Inc.
Filed
May 18, 2026, 4:15 PM ET
On May 17, 2026, Stefan D. Loren, Ph.D. notified the board of directors (the “Board”) of Cellectar Biosciences, Inc. (the “Company”), that he does not intend to stand for reelection as a Class III director at the upcoming 2026 annual meeting of the stockholders of the Company (the “Annual Meeting”), at which time his current term as a director will expire.
Departed

Guy M. Erwin II

Chief Accounting Officer
FDX · FEDEX CORP
Effective
2026-05-31
Successor
Claude F. Russ
Filed
May 18, 2026, 4:15 PM ET
On May 14, 2026, Guy M. Erwin II, Corporate Vice President and Chief Accounting Officer of FedEx Corporation (“FedEx” or the “Company”), informed the Company that he is resigning, effective May 31, 2026, to join FedEx Freight Holding Company, Inc. as Senior Vice President – Chief Accounting Officer.
Departed

Steve Herron

Chief Operating Officer
BLDR · Builders FirstSource, Inc.
Effective
2026-12-31
Successor
Mike Hiller
Filed
May 18, 2026, 4:15 PM ET
Mr. Herron has served as Chief Operating Officer of the Company since March 2023 and is retiring after over 15 years of dedicated service to the Company.
Departed

Kah Loong Randy Yeo

Director
YHC · LQR House Inc.
Effective
2026-05-12
Filed
May 18, 2026, 4:05 PM ET
On May 12, 2026, Kah Loong Randy Yeo resigned from the Board of Directors of LQR House Inc. (the “ Company ”), effective immediately.
Departed

Don Clegg

Senior Vice President of Worldwide Sales
SMCI · Super Micro Computer, Inc.
Effective
2026-05-15
Filed
May 18, 2026, 4:05 PM ET
On May 12, 2026, Mr. Don Clegg, Senior Vice President of Worldwide Sales, informed Super Micro Computer, Inc. (the “Company”) that he will retire effective May 15, 2026.
Departed

Jeremy Krol

Director
PHUN · Phunware, Inc.
Effective
2026-05-12
Filed
May 18, 2026, 11:06 AM ET
On May 12, 2026, Jeremy Krol notified the Company of his voluntary resignation from the Board of Directors.
Departed

Rick Gordon

Director
Tri-State Generation & Transmission Association, Inc.
Effective
2026-06-04
Successor
James Riggins
Filed
May 18, 2026, 9:54 AM ET
certified the election by its member, Mountain View Electric Association, Inc. (“MVEA”), of James Riggins to replace Rick Gordon, as the director representing MVEA on Tri-State’s Board of Directors effective as of June 4, 2026.
Departed

Patricia Hirano

Senior Vice President, Regulatory Affairs
SLNO · SOLENO THERAPEUTICS INC
Effective
2026-05-18
Filed
May 18, 2026, 9:06 AM ET
each of Anish Bhatnagar, M.D. (Chief Executive Officer), Jennifer Fulk (Chief Financial Officer), Patricia Hirano (Senior Vice President, Regulatory Affairs), Kristen Yen (Senior Vice President, Global Clinical Operations & Patient Advocacy), Meredith Manning (Chief Commercial Officer), Manher (AJ) Joshi (Chief Development Officer), Kevin Norrett (Chief Business Officer) and Michael Huang (Senior Vice President, Clinical Development) resigned from his or her positions as an officer
Departed

Mark Hahn

Director
SLNO · SOLENO THERAPEUTICS INC
Effective
2026-05-18
Filed
May 18, 2026, 9:06 AM ET
each of Anish Bhatnagar, M.D., Mark Hahn, Matthew Pauls, Birgitte Volck, Andrew Sinclair and Dawn Bir resigned from his or her respective positions as a member of the Company’s board of directors
Departed

Andrew Sinclair

Director
SLNO · SOLENO THERAPEUTICS INC
Effective
2026-05-18
Filed
May 18, 2026, 9:06 AM ET
each of Anish Bhatnagar, M.D., Mark Hahn, Matthew Pauls, Birgitte Volck, Andrew Sinclair and Dawn Bir resigned from his or her respective positions as a member of the Company’s board of directors
Departed

Anish Bhatnagar

Chief Executive Officer
SLNO · SOLENO THERAPEUTICS INC
Effective
2026-05-18
Filed
May 18, 2026, 9:06 AM ET
each of Anish Bhatnagar, M.D. (Chief Executive Officer), Jennifer Fulk (Chief Financial Officer), Patricia Hirano (Senior Vice President, Regulatory Affairs), Kristen Yen (Senior Vice President, Global Clinical Operations & Patient Advocacy), Meredith Manning (Chief Commercial Officer), Manher (AJ) Joshi (Chief Development Officer), Kevin Norrett (Chief Business Officer) and Michael Huang (Senior Vice President, Clinical Development) resigned from his or her positions as an officer
Departed

Anish Bhatnagar

Director
SLNO · SOLENO THERAPEUTICS INC
Effective
2026-05-18
Filed
May 18, 2026, 9:06 AM ET
each of Anish Bhatnagar, M.D., Mark Hahn, Matthew Pauls, Birgitte Volck, Andrew Sinclair and Dawn Bir resigned from his or her respective positions as a member of the Company’s board of directors
Departed

Kristen Yen

Senior Vice President, Global Clinical Operations & Patient Advocacy
SLNO · SOLENO THERAPEUTICS INC
Effective
2026-05-18
Filed
May 18, 2026, 9:06 AM ET
each of Anish Bhatnagar, M.D. (Chief Executive Officer), Jennifer Fulk (Chief Financial Officer), Patricia Hirano (Senior Vice President, Regulatory Affairs), Kristen Yen (Senior Vice President, Global Clinical Operations & Patient Advocacy), Meredith Manning (Chief Commercial Officer), Manher (AJ) Joshi (Chief Development Officer), Kevin Norrett (Chief Business Officer) and Michael Huang (Senior Vice President, Clinical Development) resigned from his or her positions as an officer
Departed

Matthew Pauls

Director
SLNO · SOLENO THERAPEUTICS INC
Effective
2026-05-18
Filed
May 18, 2026, 9:06 AM ET
each of Anish Bhatnagar, M.D., Mark Hahn, Matthew Pauls, Birgitte Volck, Andrew Sinclair and Dawn Bir resigned from his or her respective positions as a member of the Company’s board of directors
Departed

Jennifer Fulk

Chief Financial Officer
SLNO · SOLENO THERAPEUTICS INC
Effective
2026-05-18
Filed
May 18, 2026, 9:06 AM ET
each of Anish Bhatnagar, M.D. (Chief Executive Officer), Jennifer Fulk (Chief Financial Officer), Patricia Hirano (Senior Vice President, Regulatory Affairs), Kristen Yen (Senior Vice President, Global Clinical Operations & Patient Advocacy), Meredith Manning (Chief Commercial Officer), Manher (AJ) Joshi (Chief Development Officer), Kevin Norrett (Chief Business Officer) and Michael Huang (Senior Vice President, Clinical Development) resigned from his or her positions as an officer
Departed

Kevin Norrett

Chief Business Officer
SLNO · SOLENO THERAPEUTICS INC
Effective
2026-05-18
Filed
May 18, 2026, 9:06 AM ET
each of Anish Bhatnagar, M.D. (Chief Executive Officer), Jennifer Fulk (Chief Financial Officer), Patricia Hirano (Senior Vice President, Regulatory Affairs), Kristen Yen (Senior Vice President, Global Clinical Operations & Patient Advocacy), Meredith Manning (Chief Commercial Officer), Manher (AJ) Joshi (Chief Development Officer), Kevin Norrett (Chief Business Officer) and Michael Huang (Senior Vice President, Clinical Development) resigned from his or her positions as an officer
Departed

Meredith Manning

Chief Commercial Officer
SLNO · SOLENO THERAPEUTICS INC
Effective
2026-05-18
Filed
May 18, 2026, 9:06 AM ET
each of Anish Bhatnagar, M.D. (Chief Executive Officer), Jennifer Fulk (Chief Financial Officer), Patricia Hirano (Senior Vice President, Regulatory Affairs), Kristen Yen (Senior Vice President, Global Clinical Operations & Patient Advocacy), Meredith Manning (Chief Commercial Officer), Manher (AJ) Joshi (Chief Development Officer), Kevin Norrett (Chief Business Officer) and Michael Huang (Senior Vice President, Clinical Development) resigned from his or her positions as an officer
Departed

Manher (AJ) Joshi

Chief Development Officer
SLNO · SOLENO THERAPEUTICS INC
Effective
2026-05-18
Filed
May 18, 2026, 9:06 AM ET
each of Anish Bhatnagar, M.D. (Chief Executive Officer), Jennifer Fulk (Chief Financial Officer), Patricia Hirano (Senior Vice President, Regulatory Affairs), Kristen Yen (Senior Vice President, Global Clinical Operations & Patient Advocacy), Meredith Manning (Chief Commercial Officer), Manher (AJ) Joshi (Chief Development Officer), Kevin Norrett (Chief Business Officer) and Michael Huang (Senior Vice President, Clinical Development) resigned from his or her positions as an officer
Departed

Birgitte Volck

Director
SLNO · SOLENO THERAPEUTICS INC
Effective
2026-05-18
Filed
May 18, 2026, 9:06 AM ET
each of Anish Bhatnagar, M.D., Mark Hahn, Matthew Pauls, Birgitte Volck, Andrew Sinclair and Dawn Bir resigned from his or her respective positions as a member of the Company’s board of directors
Departed

Michael Huang

Senior Vice President, Clinical Development
SLNO · SOLENO THERAPEUTICS INC
Effective
2026-05-18
Filed
May 18, 2026, 9:06 AM ET
each of Anish Bhatnagar, M.D. (Chief Executive Officer), Jennifer Fulk (Chief Financial Officer), Patricia Hirano (Senior Vice President, Regulatory Affairs), Kristen Yen (Senior Vice President, Global Clinical Operations & Patient Advocacy), Meredith Manning (Chief Commercial Officer), Manher (AJ) Joshi (Chief Development Officer), Kevin Norrett (Chief Business Officer) and Michael Huang (Senior Vice President, Clinical Development) resigned from his or her positions as an officer
Departed

Dawn Bir

Director
SLNO · SOLENO THERAPEUTICS INC
Effective
2026-05-18
Filed
May 18, 2026, 9:06 AM ET
each of Anish Bhatnagar, M.D., Mark Hahn, Matthew Pauls, Birgitte Volck, Andrew Sinclair and Dawn Bir resigned from his or her respective positions as a member of the Company’s board of directors
Departed

Nicola Rossi

Chief Accounting Officer
WH · WYNDHAM HOTELS & RESORTS, INC.
Effective
2026-07-31
Successor
Christopher Androski
Filed
May 18, 2026, 6:36 AM ET
On July 31, 2026 (the “Effective Date”), Nicola Rossi, Chief Accounting Officer of Wyndham Hotels & Resorts, Inc. (the “Company”), will depart from the Company.
Departed

Scott S. Prince

Director
ARI · Apollo Commercial Real Estate Finance, Inc.
Filed
May 15, 2026, 5:26 PM ET
On May 14, 2026, Scott S. Prince, a director on the Board of Directors (the “Board”) of Apollo Commercial Real Estate Finance, Inc. (the “Company”), informed the Company that he will not be standing for re-election to the Board at the Company’s next annual meeting of stockholders.
Departed

Lee Fraser

Chief Administrative Officer
PLNH · Planet 13 Holdings Inc.
Filed
May 15, 2026, 5:18 PM ET
On April 27, 2026, Planet 13 Holdings Inc. (the "Company") entered into a separation agreement with the Company’s former Chief Administrative Officer, Lee Fraser (the "Separation Agreement").
Departed

Peter J. Bulgarelli

Executive Vice President, Outpatient Medical & Research
VTR · Ventas, Inc.
Effective
2026-05-01
Filed
May 15, 2026, 5:15 PM ET
On May 12, 2026, in connection with his previously disclosed retirement on May 1, 2026, Ventas, Inc. (the “Company”) entered into a separation and release agreement with Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research, Ventas, Inc. and President and CEO, Lillibridge Healthcare Services, Inc.
Departed

Scott Ciccone

Chief Accounting Officer
Sculptor Diversified Real Estate Income Trust, Inc.
Effective
2026-05-15
Successor
Christine Yap
Filed
May 15, 2026, 5:05 PM ET
On May 12, 2026, Scott Ciccone notified the Company of his resignation as Chief Accounting Officer of the Company effective as of May 15, 2026. Mr. Ciccone’s resignation was not due to any disagreement with the Company
Departed

Mickie Henshall

Director
VNRX · VOLITIONRX LTD
Filed
May 15, 2026, 4:45 PM ET
On May 12, 2026, Mickie Henshall notified the Board of Directors (the “Board”) of VolitionRx Limited (the “Company”) of her decision not to stand for re-election to the Board at the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”).
Departed

Harvey S. Kanter

President and Chief Executive Officer
DXLG · DESTINATION XL GROUP, INC.
Effective
2026-08-11
Filed
May 15, 2026, 4:22 PM ET
Accordingly, Mr. Kanter’s Employment Agreement will expire and his employment with the Company will terminate on August 11, 2026.
Departed

Dane Almassy

Chief Commercial Officer
LOCL · Local Bounti Corporation/DE
Effective
2026-05-14
Filed
May 15, 2026, 4:21 PM ET
On May 14, 2026, Local Bounti Corporation (the “Company”) notified Dane Almassy, the Company’s Chief Commercial Officer, that his employment with the Company ended effective May 14, 2026 (the “Separation Date”).
Departed

Randall Keys

Director
USEG · US ENERGY CORP
Effective
2026-05-08
Filed
May 15, 2026, 4:16 PM ET
Effective May 8, 2026, Randall Keys ceased to serve as a member of the Board of Directors (the “Board”) of U.S. Energy Corp. (the “Company”) upon the expiration of his term
Departed

Felix Lauscher

Chief Operating Officer
AVXL · ANAVEX LIFE SCIENCES CORP.
Effective
2026-05-11
Filed
May 15, 2026, 4:15 PM ET
On May 11, 2026, Felix Lauscher, who had held the title of Chief Operating Officer of Anavex Life Sciences Corp. (the “Company”) since March 1, 2026, departed from the Company as part of a broader reorganization of duties at the Company following the appointment of Dr. Terrie Kellmeyer as the Company’s Interim Chief Executive Officer.
Departed

Richard A. Hubbell

director
MPX · MARINE PRODUCTS CORP
Effective
2026-05-15
Filed
May 15, 2026, 4:15 PM ET
Richard A. Hubbell, Jerry W. Nix, Susan R. Bell, Patrick J. Gunning, Gary Kolstad, Amy R. Kreisler, Stephen E. Lewis, Ben M. Palmer, Timothy C. Rollins and John F. Wilson.
Departed

Richard A. Hubbell

Other Named Officer
MPX · MARINE PRODUCTS CORP
Effective
2026-05-15
Filed
May 15, 2026, 4:15 PM ET
the following named executive officers of Marine Products voluntarily resigned from any and all of their respective director, manager, or officer positions with Marine Products or any of its subsidiaries: Richard A. Hubbell, Ben M. Palmer and Michael L. Schmit.
Departed

Ben M. Palmer

director
MPX · MARINE PRODUCTS CORP
Effective
2026-05-15
Filed
May 15, 2026, 4:15 PM ET
Richard A. Hubbell, Jerry W. Nix, Susan R. Bell, Patrick J. Gunning, Gary Kolstad, Amy R. Kreisler, Stephen E. Lewis, Ben M. Palmer, Timothy C. Rollins and John F. Wilson.
Departed

John F. Wilson

director
MPX · MARINE PRODUCTS CORP
Effective
2026-05-15
Filed
May 15, 2026, 4:15 PM ET
Richard A. Hubbell, Jerry W. Nix, Susan R. Bell, Patrick J. Gunning, Gary Kolstad, Amy R. Kreisler, Stephen E. Lewis, Ben M. Palmer, Timothy C. Rollins and John F. Wilson.
Departed

Ben M. Palmer

Other Named Officer
MPX · MARINE PRODUCTS CORP
Effective
2026-05-15
Filed
May 15, 2026, 4:15 PM ET
the following named executive officers of Marine Products voluntarily resigned from any and all of their respective director, manager, or officer positions with Marine Products or any of its subsidiaries: Richard A. Hubbell, Ben M. Palmer and Michael L. Schmit.
Departed

Timothy C. Rollins

director
MPX · MARINE PRODUCTS CORP
Effective
2026-05-15
Filed
May 15, 2026, 4:15 PM ET
Richard A. Hubbell, Jerry W. Nix, Susan R. Bell, Patrick J. Gunning, Gary Kolstad, Amy R. Kreisler, Stephen E. Lewis, Ben M. Palmer, Timothy C. Rollins and John F. Wilson.
Departed

Amy R. Kreisler

director
MPX · MARINE PRODUCTS CORP
Effective
2026-05-15
Filed
May 15, 2026, 4:15 PM ET
Richard A. Hubbell, Jerry W. Nix, Susan R. Bell, Patrick J. Gunning, Gary Kolstad, Amy R. Kreisler, Stephen E. Lewis, Ben M. Palmer, Timothy C. Rollins and John F. Wilson.
Departed

Jerry W. Nix

director
MPX · MARINE PRODUCTS CORP
Effective
2026-05-15
Filed
May 15, 2026, 4:15 PM ET
Richard A. Hubbell, Jerry W. Nix, Susan R. Bell, Patrick J. Gunning, Gary Kolstad, Amy R. Kreisler, Stephen E. Lewis, Ben M. Palmer, Timothy C. Rollins and John F. Wilson.
Departed

Patrick J. Gunning

director
MPX · MARINE PRODUCTS CORP
Effective
2026-05-15
Filed
May 15, 2026, 4:15 PM ET
Richard A. Hubbell, Jerry W. Nix, Susan R. Bell, Patrick J. Gunning, Gary Kolstad, Amy R. Kreisler, Stephen E. Lewis, Ben M. Palmer, Timothy C. Rollins and John F. Wilson.
Departed

Stephen E. Lewis

director
MPX · MARINE PRODUCTS CORP
Effective
2026-05-15
Filed
May 15, 2026, 4:15 PM ET
Richard A. Hubbell, Jerry W. Nix, Susan R. Bell, Patrick J. Gunning, Gary Kolstad, Amy R. Kreisler, Stephen E. Lewis, Ben M. Palmer, Timothy C. Rollins and John F. Wilson.
Departed

Susan R. Bell

director
MPX · MARINE PRODUCTS CORP
Effective
2026-05-15
Filed
May 15, 2026, 4:15 PM ET
Richard A. Hubbell, Jerry W. Nix, Susan R. Bell, Patrick J. Gunning, Gary Kolstad, Amy R. Kreisler, Stephen E. Lewis, Ben M. Palmer, Timothy C. Rollins and John F. Wilson.
Departed

Michael L. Schmit

Other Named Officer
MPX · MARINE PRODUCTS CORP
Effective
2026-05-15
Filed
May 15, 2026, 4:15 PM ET
the following named executive officers of Marine Products voluntarily resigned from any and all of their respective director, manager, or officer positions with Marine Products or any of its subsidiaries: Richard A. Hubbell, Ben M. Palmer and Michael L. Schmit.
Departed

Gary Kolstad

director
MPX · MARINE PRODUCTS CORP
Effective
2026-05-15
Filed
May 15, 2026, 4:15 PM ET
Richard A. Hubbell, Jerry W. Nix, Susan R. Bell, Patrick J. Gunning, Gary Kolstad, Amy R. Kreisler, Stephen E. Lewis, Ben M. Palmer, Timothy C. Rollins and John F. Wilson.
Departed

Austin Charette

Principal Accounting Officer
AGEN · AGENUS INC
Effective
2026-05-29
Filed
May 15, 2026, 4:08 PM ET
On May 12, 2026, Austin Charette, Senior Director, Financial Reporting and Compliance and Principal Accounting Officer of Agenus Inc. (the "Company"), informed the Company he will be resigning effective May 29, 2026.
Departed

Svai Sanford

Chief Financial Officer
RANI · Rani Therapeutics Holdings, Inc.
Filed
May 15, 2026, 4:08 PM ET
On May 12, 2026, Svai Sanford, the Company’s Chief Financial Officer, advised the Company that he will resign from his position following the appointment of his successor.
Departed

Michael Woods

Director
DRDB · Roman DBDR Acquisition Corp. II
Effective
2026-05-11
Successor
Hunter C. Gary
Filed
May 15, 2026, 4:06 PM ET
On May 11, 2026, Michael Woods resigned as a director of Roman DBDR Acquisition Corp. II (the “Company”), effective immediately.

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.